Repurposing endogenous type II CRISPR‐Cas9 system for genome editing in Streptococcus thermophilus
Biotechnology and Bioengineering · 2024-02 · 121 (2) · 749-756
DOI: 10.1002/bit.28608 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology and Bioengineering, online erschienen am 23.11.2023. Verfasst von Shuai Ma und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Microbial Technology, Shandong University, Qingdao, People's Republic of China. Hauptthemen laut MEDLINE: Gene Editing, CRISPR-Cas Systems. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 19 Literaturangaben. Gefördert von: National Key Research and Development Program of China.
Abstract (Originalsprache)
Streptococcus thermophilus has been extensively used in industrial milk fermentation. However, lack of efficient genetic manipulation approaches greatly hampered the industrial application of this species. Here, we repurposed the endogenous CRISPR1 and CRISPR3 systems, both belong to type II‐A CRISPR‐Cas9, by delivering a self‐targeting CRISPR array with DNA repair template into S. thermophilus LMD‐9. We achieved 785‐bp deletion in lac Z gene by repurposing CRISPR1 and CRISPR3 systems with efficiencies of 35% and 59%, respectively, when 1‐kb DNA repair template was provided. While providing with 1.5‐kb repair template, the editing efficiency for deletion in lacZ gene reached 90% using CRISPR3 systems. Diverse editing outcomes encompassing a stop code insertion and single nucleotide variation within lac Z, as well as a 234‐bp DNA fragment insertion upstream of ster_0903 , were generated with high efficiencies of 75%–100% using the CRISPR3 system. Harnessing the customized endogenous CRISPR3 system to target six genes of eps gene cluster, we obtained six single‐gene knockout mutants with efficiencies of 29%–80%, and proved that the eps A, eps E, and eps G were the key genes affecting exopolysaccharides biosynthesis in S. thermophilus LMD‐9. Altogether, repurposing the native type II‐A CRISPR‐Cas9 can be served as a toolkit for precise genome engineering in S. thermophilus for biotechnological applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Microbial Technology, Shandong University, Qingdao, People's Republic of China.
- Tianjin Key Laboratory of Microbial Functional Genomics, TEDA Institute of Biological Sciences and Biotechnology, Nankai University, Tianjin, People's Republic of China.
- Bloomage Biotechnology Corporation Limited, Jinan, People's Republic of China.
ORCID-Profile: Shuai Ma, Qingsheng Qi
Förderung
- National Key Research and Development Program of China
Zitieren
APA
Ma, S., Wang, F., Xuejing, Z., Liping, Q., Xueping, G., Lu, X., & Qi, Q. (2024). Repurposing endogenous type II CRISPR‐Cas9 system for genome editing in Streptococcus thermophilus. Biotechnology and Bioengineering, 121(2), 749-756. https://doi.org/10.1002/bit.28608
Vancouver
Ma S, Wang F, Xuejing Z, Liping Q, Xueping G, Lu X, et al. Repurposing endogenous type II CRISPR‐Cas9 system for genome editing in Streptococcus thermophilus. Biotechnology and Bioengineering. 2024;121(2):749-756. doi:10.1002/bit.28608
BibTeX
@article{Ma2024,
author = {Ma, Shuai and Wang, Feiyu and Xuejing, Zhang and Liping, Qiao and Xueping, Guo and Lu, Xuemei and Qi, Qingsheng},
title = {Repurposing endogenous type II CRISPR‐Cas9 system for genome editing in Streptococcus thermophilus},
journal = {Biotechnology and Bioengineering},
year = {2024},
volume = {121},
number = {2},
pages = {749--756},
doi = {10.1002/bit.28608}
}
EUVIMED